drugset / Trial / NCT02546050

The Effect of Metformin on Composition of Human Gut Bacteria

NCT02546050 ↗

Phase 1 Completed 26 enrolled Oluf Borbye Pedersen
NaSingle-groupOpen-labelBasic science

Summary

OBJECTIVE: Investigate structural changes in the human gut microbiota and associated changes in metabolic markers in urine, saliva, blood and fecal samples following metformin treatment. DESIGN: An, 18 week, one-armed cross over intervention trial consisting of a 6-week pre-intervention period, 6-week intervention period and a 6-week post-intervention period. 25 healthy young men will be included in the trial. INTERVENTION: Six-week Metformin treatment to young healthy men.

Timeline

Start
2015-06
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1000 mg —

Indications

No indication recorded.